Your browser doesn't support javascript.
loading
A placebo-controlled proof-of-concept study of alirocumab on postprandial lipids and vascular elasticity in insulin-treated patients with type 2 diabetes mellitus.
Burggraaf, Benjamin; Pouw, Nadine M C; Arroyo, Salvador Fernández; van Vark-van der Zee, Leonie C; van de Geijn, Gert-Jan M; Birnie, Erwin; Huisbrink, Jeannine; van der Zwan, Ellen M; Mulder, Monique T; Rensen, Patrick C N; de Herder, Wouter W; Cabezas, Manuel Castro.
Afiliación
  • Burggraaf B; Department of Internal Medicine, Center for Diabetes and Vascular Medicine, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands.
  • Pouw NMC; Department of Clinical Chemistry, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands.
  • Arroyo SF; Departament de Medicina i Cirurgia, Unitat de Recerca Biomèdica, Universitat Rovira i Virgili, Tarragona, Spain.
  • van Vark-van der Zee LC; Department of Internal Medicine, Division of Pharmacology, Vascular and Metabolic Diseases, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • van de Geijn GM; Department of Clinical Chemistry, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands.
  • Birnie E; Department of Statistics and Education, Franciscus Academy, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands.
  • Huisbrink J; Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • van der Zwan EM; Department of Pharmacy, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands.
  • Mulder MT; Department of Clinical Chemistry, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands.
  • Rensen PCN; Department of Internal Medicine, Division of Pharmacology, Vascular and Metabolic Diseases, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • de Herder WW; Department of Internal Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, the Netherlands.
  • Cabezas MC; Department of Internal Medicine, Section of Endocrinology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Diabetes Obes Metab ; 22(5): 807-816, 2020 05.
Article en En | MEDLINE | ID: mdl-31912632
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Proproteína Convertasa 9 Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans / Male Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Proproteína Convertasa 9 Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans / Male Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido